David Scott Miller, MD, F.A.C.O.G., F.A.C.S.
Director & Dallas Foundation Chair in Gyn. Onc.
The University of Texas Southwestern Medical Center
Dept. of OB/GYN
5323 Harry Hines Blvd., Ste. E6.102
Dallas,
TX
USA
75390-9032
Papers:
133 - Focused Plenary
Results of Gynecologic Oncology Group (GOG) 229K: a phase II trial of BIBF-1120 for women with advanced, recurrent, or metastatic endometrial carcinoma
184 - Poster Session A
Factors associated with clinical trial screening failures in gynecologic oncology
Late Breaking Abstract 2
A phase II study to determine the response to second curettage as initial management for persistent "low-risk" non-metastatic gestational trophoblastic neoplasia: A Gynecologic Oncology Group study